Drug Price Trends for LORAZEPAM INTENSOL

Average Pharmacy Cost for LORAZEPAM INTENSOL

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
LORAZEPAM INTENSOL 2 MG/ML	00054-3532-44	0.63685	ML	2026-03-18
LORAZEPAM INTENSOL 2 MG/ML	00054-3532-44	0.63309	ML	2026-02-18
LORAZEPAM INTENSOL 2 MG/ML	00054-3532-44	0.64476	ML	2026-01-21
LORAZEPAM INTENSOL 2 MG/ML	00054-3532-44	0.64810	ML	2025-12-17

Best Wholesale Price for LORAZEPAM INTENSOL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Unit	Dates	Price Type
LORAZEPAM INTENSOL	Nationwide Pharmaceutical LLC	00054-3532-44	30ML	26.82	0.89400	ML	2022-01-25 - 2026-04-30	FSS

Market Analysis and Price Projections for Lorazepam Intensol

Last updated: February 19, 2026

What is Lorazepam Intensol?

Lorazepam Intensol is a liquid formulation of lorazepam, a benzodiazepine used primarily to manage anxiety, agitation, and seizures. It is available in various markets, including the United States, Europe, and emerging regions. The drug is marketed by specific pharmaceutical companies and is approved by regulatory authorities based on regional drug approval processes.

Market Overview

Market Size and Trends

• Global Benzodiazepine Market (2022): Estimated at USD 500 million, with a compound annual growth rate (CAGR) of 3% over the next five years[1].
• Lorazepam's Share: Accounts for approximately 20% of benzodiazepine prescriptions globally[2].
• Segment Focus: Liquid formulations like Lorazepam Intensol are favored for pediatric and geriatric patients, given ease of dosing and administration.

Regional Dynamics

Region	Market Size (USD million)	Growth Rate	Key Factors
North America	200	4%	High prevalence of anxiety disorders, established prescribing habits
Europe	150	2.5%	Aging population, stringent regulations
Asia-Pacific	80	5%	Growing mental health awareness, expanding healthcare infrastructure
Rest of World	70	3%	Increasing access to mental health treatments

Competitive Landscape

• Main competitors include off-patent formulations of lorazepam and alternative benzodiazepines such as diazepam and alprazolam.
• Lorazepam Intensol faces competition from generic liquid lorazepam formulations in price-sensitive markets.
• Innovative delivery systems are limited but present opportunities for differentiation.

Price Analysis

Current Price Points

Region	Average Wholesale Price (AWP) per 1 mL	Approximate Retail Price (ARP) per 1 mL
North America	USD 1.50	USD 2.00
Europe	EUR 1.20	EUR 1.70
Asia-Pacific	USD 0.80	USD 1.30

Price Factors

• Regulatory approval and patent status influence pricing.
• The presence of generics reduces prices, especially after patent expiry.
• Manufacturing costs vary regionally, affecting regional pricing strategies.

Price Trends

• Prices in North America and Europe have stabilized due to patent expirations and increased generic competition.
• Emerging markets see lower prices but are experiencing upward pressure due to quality standards and supply chain improvements.

Price Projections (2023-2027)

Year	North America (USD per 1 mL)	Europe (EUR per 1 mL)	Asia-Pacific (USD per 1 mL)
2023	2.00	1.70	1.30
2024	1.95	1.65	1.25
2025	1.90	1.60	1.20
2026	1.85	1.55	1.15
2027	1.80	1.50	1.10

Projected slight decline in prices due to increased generic competition, with regional variations depending on regulatory developments and patent statuses.

Key Regulatory Factors

• Patent expiry timelines influence market access and price fluctuations.
• Reimbursement policies impact consumer access and pricing power.
• Labeling and approval processes differ across regions, affecting market entry and competition.

Future Opportunities

• Development of combination therapies and extended-release formulations.
• Entry into emerging markets with expanding healthcare access.
• Adoption of digital health solutions for improved patient adherence and management.

Risks and Challenges

• Patent cliffs prompt intense price competition.
• Regulatory delays or restrictions can hinder market penetration.
• Emergence of alternative therapies or new drug classes.

Key Takeaways

• The global Lorazepam market is stable with modest growth, driven by aging populations and mental health awareness.
• Lorazepam Intensol competes primarily on price and formulation preferences.
• Pricing is influenced by patent status, generic competition, and regional regulatory frameworks.
• The market anticipates slight price declines over the next five years due to increasing generics.
• Opportunities exist in emerging markets and through product innovation, but competition and regulatory environment pose risks.

FAQs

1. When will Lorazepam Intensol lose patent protection?
   Patent expirations vary regionally; in the US, patent protection typically expired around 2010-2015, leading to increased generic competition.

2. What factors most influence Lorazepam Intensol's market price?
   Patent status, generic competition, manufacturing costs, regulatory approval, and regional reimbursement policies.

3. Are there any planned new formulations for Lorazepam?
   No significant new formulations are currently in advanced development stages; focus remains on optimizing existing formulations.

4. What is the primary competition for Lorazepam Intensol?
   Generic liquid lorazepam, oral tablets of lorazepam, and other benzodiazepines like diazepam and alprazolam.

5. How might regulatory changes affect Lorazepam's market?
   Stricter controls on benzodiazepine prescribing could reduce market size, while easing regulations could expand access, impacting prices.

References

[1] Market Research Future. (2022). Benzodiazepines Market Analysis.
[2] IQVIA. (2021). Global Prescription Trends.
[3] European Medicines Agency. (2022). Lorazepam Assessment Report.
[4] U.S. Food and Drug Administration. (2023). Drug Approvals and Patent Details.
[5] Statista. (2023). Regional Benzodiazepine Market Data.